{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "GBTG",
  "name": "Global Business Travel Group, Inc.",
  "url": "https://frontierpicks.com/dossiers/GBTG/",
  "json_url": "https://frontierpicks.com/dossiers/GBTG.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a5",
    "n": 5
  },
  "current_thesis": "Take-private in its final leg: stockholders adopted the $9.50 Long Lake merger on 2026-08-03, and the 2026-08-14 close of $9.46 leaves $0.04 gross against a roughly 37% break tail to the unaffected $5.93. Only undated offshore regulatory clearances remain, against a 2026-11-02 outside date.",
  "invalidation_trigger": "A daily close below $9.00 (a >5% discount to the $9.50 cash terms, giving up the post-2026-05-04 deal shelf). Secondarily, an Item 1.02 8-K terminating the merger, an 8-K disclosing an in-depth EU/UK review, or the outside date extended to 2027-02-02 with no articulated clearance path.",
  "catalyst_date": null,
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "m-and-a-special-situations",
    "consumer-discretionary-rotation"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "2026-05-04: Long Lake Management (General Catalyst + Alpha Wave backed) to acquire Amex GBT at $9.50/share cash, ~$6.3B; stock +57% on announcement.",
    "2026-05-04: Long Lake Management (General Catalyst + Alpha Wave backed) to acquire Amex GBT at $9.50/share cash, ~$6.3B equity value; 60.2% premium to 5/1 close of $5.93; stock +57% on announcement.",
    "2026-05-04: Long Lake Management (General Catalyst + Alpha Wave) to acquire Amex GBT at $9.50/share cash, ~$6.3B; 60.2% premium to 5/1 close of $5.93; stock +57% on announcement.",
    "Earnings calls and financial guidance have been suspended since 2026-05-04 while the merger is pending; results arrive as a release and 10-Q only.",
    "On completion the Class A shares are delisted from the NYSE and deregistered under the Exchange Act.",
    "Delaware statutory appraisal rights are available; the proxy states fair value could be determined above, at, or below the $9.50 merger consideration.",
    "The merger agreement contains no go-shop; the board may consider a Superior Proposal only subject to Parent matching rights.",
    "Outside date is 2026-11-02, extendable to 2027-02-02 if regulatory approvals remain outstanding.",
    "Voting agreements from American Express, Expedia, Qatar Investment Authority and BlackRock cover ~69% of the 522,373,443 shares outstanding at the 2026-07-06 record date."
  ],
  "body_markdown": "## Current Thesis\nThe shareholder gate is closed. Stockholders adopted the Long Lake merger agreement at the virtual special meeting on **2026-08-03**, confirmed in the company's own **2026-08-04** Q2 release, which restated the closing expectation as \"second half of 2026, subject to satisfaction of customary closing conditions, including receipt of regulatory approvals.\" The stock closed **$9.46 on 2026-08-14** against the **$9.50** cash consideration — $0.04 gross, roughly 0.4% — versus the $9.44 print of 2026-07-31. Every remaining condition is offshore and opaque: EU foreign-subsidies clearance, non-US antitrust (UK CMA notified **2026-05-21**) and foreign-investment/security reviews, none of which carry a public calendar date. The narrative leg on offer is completion of a locked take-private at a fixed cap, with the entire distribution now shaped by a low-probability, high-severity break to the unaffected **2026-05-01 close of $5.93**.\n\n**The narrative is saturated.** Coverage peaked in the 2026-05-04 announcement week; the vote (2026-08-03) and the Q2 print (2026-08-04) have both elapsed; the spread has compressed from ~$0.06 at the 2026-07-31 close to $0.04 at 2026-08-14; and there is no scheduled public event left before the **2026-11-02** outside date. New marginal bid at $9.46 buys four cents of contractual upside.\n\n## Bull Case\n- **Vote done, and it was not close to being informative.** Preliminary results announced 2026-08-03 show adoption of the merger agreement plus the advisory compensation proposal; voting agreements from American Express, Expedia, Qatar Investment Authority and BlackRock covered ~69% of the 522,373,443 shares outstanding at the 2026-07-06 record date.\n- **US antitrust cleared 2026-06-22** — the HSR waiting period expired, per the DEFM14A filed 2026-07-06.\n- **The asset accelerated into the close.** Q2 2026 (released 2026-08-04): revenue **$870M, +38% YoY**; adjusted EBITDA **$178M, +34%**; gross profit **$494M** at a **57%** margin; free cash flow **$103M**. LTM Total New Wins Value **$3.5B** including Google, Koch and Pfizer, with customer retention at **95%**.\n- **Revenue beat the sell-side line** — $870M against a $823.3M consensus estimate (2026-08-04). A buyer walking from a business printing +38% revenue growth would be walking from an improving asset, which is not the usual shape of a financing-driven break.\n- **Break-fee asymmetry favours the sponsor completing.** PREM14A (2026-05-28): **$270M** parent reverse-termination fee against a **$200M** company fee. Equity from General Catalyst, Alpha Wave and Koch Equity Development; debt commitments from JPMorgan Chase, Bank of America, Citigroup and MUFG (2026-05-04). Financing is committed and is not a closing condition.\n\n## Bear Case\n- **The payoff is inverted and has got worse.** $0.04 of contractual upside from the 2026-08-14 close of $9.46, against reversion toward the unaffected **$5.93** on a break — roughly −37% severity for a four-cent claim.\n- **Earnings quality did not follow revenue.** Q2 EPS came in at **$0.03 against a $0.12 consensus** (2026-08-04). With calls and guidance suspended since 2026-05-04, there is no management commentary to contextualise it, and no operating result can lift the shares through the $9.50 cap in any case.\n- **No valuation floor beneath the terms.** The 2026-07-24 supplemental disclosure put Rothschild & Co's own work on the record: selected public companies **$6.25–$9.00**, precedent transactions **$6.00–$7.50**, DCF **$6.50–$10.00**. The consideration sits at or above the top of two of the three ranges.\n- **Residual risk is entirely non-US and undated.** EU foreign-subsidies review, UK CMA and foreign-investment/security clearances were all open at the 2026-07-06 proxy and nothing since has disclosed their completion. A Qatar Investment Authority stake in a platform holding global corporate-travel itinerary data is the kind of fact that lengthens foreign-investment review rather than shortening it.\n- **Appraisal is not a backstop.** The proxy states Delaware fair value could be determined above, at, or below $9.50.\n- **Time is a one-way cost.** Outside date **2026-11-02**, extendable to **2027-02-02** if regulatory approvals remain outstanding. Each week of extension divides an already thin gross spread across a longer holding window.\n\n## Setup & Price Structure\n- **$9.46 close (2026-08-14)**, 0.5% below the 52-week high of **$9.51**; three-month return **+1.3%**. The adjusted series has printed marginally above the $9.50 cash consideration, which bounds how much upside any technical structure can express.\n- **RSI(14) at 72.7** is an artifact of a price pinned beneath a fixed cash cap, not a momentum signal. The same reading on an operating equity would describe an extended trend; here it describes a spread grinding shut.\n- **The relevant structure is a shelf, not a trend.** The stock has held a $9.3–$9.5 band since mid-July, with $9.50 as a hard ceiling and the unaffected $5.93 as the gap-risk reference below. There is no base to break out from and no rising moving average that means anything.\n- thin turnover consistent with an arbitrage-held register rather than active discretionary flow. No earnings date is pending (calls and guidance suspended 2026-05-04, results now arrive as a release plus 10-Q only). the last visible action was a target reduction on 2026-05-05 as coverage repriced to the deal.\n- **Capital structure at the 2026-07-24 8-K:** debt approximately **$1.534B**, cash and equivalents approximately **$442M**, pension liabilities approximately **$122M**, on approximately **534.3M** fully diluted shares.\n\n## Catalyst Calendar (next 30 days)\n- **2026-08-17 → 2026-09-15: no scheduled company event.** The 2026-08-03 special meeting and the 2026-08-04 Q2 release have both elapsed; there is no earnings call, no guidance update and no investor day while the merger is pending.\n- **Undated, any session:** an 8-K disclosing receipt of the remaining offshore clearances, or a definitive closing date. This is the only public disclosure that can move completion odds before November.\n- **~2026-09-30 (est.):** the outer edge of a plausible clearance window if the company's \"second half of 2026\" language (2026-08-04) is to hold with settlement mechanics attached.\n- **2026-11-02:** outside date under the merger agreement, extendable to 2027-02-02 for outstanding regulatory approvals.\n- **~2026-11-05 (est.):** Q3 2026 results, relevant only if the company is still public.\n- **2027-02-02:** extended outside date; failure to close by then permits termination.\n\n## What Would Change Our Mind\nThe break would not arrive through the price first — it would arrive as an Item 1.02 8-K terminating the merger agreement, an 8-K disclosing an in-depth or Phase 2 review at the European Commission or the CMA, or a disclosed extension of the outside date to 2027-02-02 without an articulated clearance path. Any of those turns a four-cent claim into a mark-to-fundamentals problem, with Rothschild's precedent-transaction range of $6.00–$7.50 as the honest reference for where the equity settles.\n\nExpressed as a gradeable level: **a daily close below $9.00** — a discount wider than 5% to the $9.50 terms — is the market pricing meaningful non-completion, and a close below $8.50 gives up the shelf the stock has held since 2026-05-04. In the other direction, the thesis does not \"work\" so much as terminate: on completion the Class A shares are delisted from the NYSE and deregistered, and the security ceases to exist as a tradable claim.\n\n## Correlation Notes\n- While the cap binds, the price series behaves like a short-dated credit instrument on completion probability rather than a corporate-travel equity. Q2's +38% revenue growth (2026-08-04) moved the shares by cents, which is the practical evidence for that.\n- The live correlation is to regulatory stance in Brussels and London toward US-sponsor take-privates with a sovereign shareholder on the register, not to airline capacity, hotel rates or consumer-discretionary flow.\n- On a break, the correlation set flips immediately to leveraged travel-services comparables and to the company's own capital structure — approximately $1.534B of debt against approximately $442M of cash (2026-07-24) — with no guidance and no earnings call available to defend a re-rating.\n- Cross-read for other pending take-privates: the outcome here is a data point on how long EU foreign-subsidies and UK merger reviews are running for sponsor-backed cross-border deals signed in mid-2026, and the 2026-11-02 outside date is when that data point resolves.",
  "first_seen": "2026-05-05",
  "last_analyzed": "2026-08-16T16:55:25+00:00",
  "last_synthesized": "2026-08-16",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}